Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Revenue: 2020-2021

Historic Revenue for Cardiol Therapeutics (CRDL) over the last 2 years, with Dec 2021 value amounting to $62,847.

  • Cardiol Therapeutics' Revenue fell 25.54% to -$10.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$35.5 million, marking a year-over-year change of. This contributed to the annual value of $62,847 for FY2021, which is 100.41% up from last year.
  • As of FY2021, Cardiol Therapeutics' Revenue stood at $62,847, which was up 100.41% from -$15.4 million recorded in FY2020.
  • Cardiol Therapeutics' Revenue's 5-year high stood at $62,847 during FY2021, with a 5-year trough of -$15.4 million in FY2020.
  • Its 2-year average for Revenue is -$7.7 million, with a median of -$7.7 million in 2020.
  • Data for Cardiol Therapeutics' Revenue shows a peak YoY skyrocketed of 100.41% (in 2021) over the last 5 years.
  • Over the past 2 years, Cardiol Therapeutics' Revenue (Yearly) stood at -$15.4 million in 2020, then soared by 100.41% to $62,847 in 2021.